February 1, 2023
Rapid Dose Therapeutics Reports Fiscal Year 2022 Financial ResultsSign up to get full access to all our latest Press Releases
Sign UpSign up to get full access to all our latest Press Releases
Sign UpRAPID DOSE THERAPEUTICS INC.
Listing/Symbol: CSE: DOSE
Fiscal Year-End: February 28
Auditors: MNP
Legal Counsel:
Harris & Harris
c/o Greg Harris
Share Structure
Shares issued & outstanding
Shares outstanding September 30, 2021
Common Shares 103,213,742
Reserved for issuance:
Warrants 21,652,433
Options 9,821,000
Fully diluted _______________
134,687,175
For inquiries
Dara Willis
DWCommunications
Email: dara@dwcomm.ca
Phone: 416-836-9272